glyburide has been researched along with Acidosis, Diabetic in 12 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " At presentation, the acute C-peptide response to glucagon in obese DKA patients was lower than in patients with hyperglycemia (P < 0." | 5.08 | Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. ( Clark, WS; Steen, MT; Umpierrez, GE, 1997) |
| "A male infant patient developed diabetic ketoacidosis at 2 months-of-age due to the heterozygous ABCC8 gene mutation (p." | 1.56 | Neonatal diabetes caused by the heterozygous Pro1198Leu mutation in the ABCC8 gene in a male infant: 6-year clinical course. ( Akamizu, T; Ariyasu, H; Doi, A; Furuta, H; Furuta, M; Iwakura, H; Iwamoto, M; Matsuno, S; Matsutani, N; Miyawaki, M; Morita, S; Nishi, M; Shima, Y; Suzuki, H; Uraki, S, 2020) |
| "Diabetes mellitus is a metabolic disease characterised by chronically high glucose levels." | 1.42 | Permanent neonatal diabetes mellitus - a case report of a rare cause of diabetes mellitus in East Africa. ( Bahendeka, S; Muhame, MR; Nyangabyaki-Twesigye, C, 2015) |
| "A 5-week-old boy presented with diabetic ketoacidosis." | 1.37 | Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene. ( Joshi, R; Phatarpekar, A, 2011) |
| "Some patients with type 2 diabetes present with ketoacidosis and require insulin treatment." | 1.30 | Atypical ketoacidosis in type 2 diabetes. ( Goldberg, RB; Machado, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Yadav, A | 3 |
| Kumar, R | 3 |
| Rawat, A | 3 |
| Venkatesan, R | 3 |
| Uraki, S | 1 |
| Furuta, H | 1 |
| Miyawaki, M | 1 |
| Matsutani, N | 1 |
| Shima, Y | 1 |
| Iwamoto, M | 1 |
| Matsuno, S | 1 |
| Morita, S | 1 |
| Furuta, M | 1 |
| Doi, A | 1 |
| Iwakura, H | 1 |
| Ariyasu, H | 1 |
| Nishi, M | 1 |
| Suzuki, H | 1 |
| Akamizu, T | 1 |
| Nyangabyaki-Twesigye, C | 1 |
| Muhame, MR | 1 |
| Bahendeka, S | 1 |
| Lauridsen, MH | 1 |
| Boesgaard, TW | 1 |
| Pedersen, OB | 1 |
| Hansen, T | 1 |
| Hertz, B | 1 |
| Joshi, R | 1 |
| Phatarpekar, A | 1 |
| Letha, S | 1 |
| Mammen, D | 1 |
| Valamparampil, JJ | 1 |
| Lunetta, M | 2 |
| Presti, C | 2 |
| Mughini, MT | 2 |
| Mughini, L | 2 |
| Umpierrez, GE | 1 |
| Clark, WS | 1 |
| Steen, MT | 1 |
| Goldberg, RB | 1 |
| Machado, R | 1 |
| Ball, S | 1 |
| Woods, HF | 1 |
| Alberti, KG | 1 |
| Weber, B | 1 |
1 review available for glyburide and Acidosis, Diabetic
| Article | Year |
|---|---|
[Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
Topics: Aged; Ambulatory Care; Biguanides; Diabetes Mellitus; Diabetic Ketoacidosis; Drug Combinations; Fema | 1980 |
1 trial available for glyburide and Acidosis, Diabetic
| Article | Year |
|---|---|
Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.
Topics: Adult; Black or African American; Black People; Blood Glucose; C-Peptide; Combined Modality Therapy; | 1997 |
10 other studies available for glyburide and Acidosis, Diabetic
| Article | Year |
|---|---|
Neonatal diabetes with a rare LRBA mutation.
Topics: Adaptor Proteins, Signal Transducing; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; I | 2022 |
Neonatal diabetes with a rare LRBA mutation.
Topics: Adaptor Proteins, Signal Transducing; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; I | 2022 |
Neonatal diabetes with a rare LRBA mutation.
Topics: Adaptor Proteins, Signal Transducing; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; I | 2022 |
Neonatal diabetes with a rare LRBA mutation.
Topics: Adaptor Proteins, Signal Transducing; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; I | 2022 |
Neonatal diabetes with a rare LRBA mutation.
Topics: Adaptor Proteins, Signal Transducing; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; I | 2022 |
Neonatal diabetes with a rare LRBA mutation.
Topics: Adaptor Proteins, Signal Transducing; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; I | 2022 |
Neonatal diabetes with a rare LRBA mutation.
Topics: Adaptor Proteins, Signal Transducing; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; I | 2022 |
Neonatal diabetes with a rare LRBA mutation.
Topics: Adaptor Proteins, Signal Transducing; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; I | 2022 |
Neonatal diabetes with a rare LRBA mutation.
Topics: Adaptor Proteins, Signal Transducing; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; I | 2022 |
Neonatal diabetes caused by the heterozygous Pro1198Leu mutation in the ABCC8 gene in a male infant: 6-year clinical course.
Topics: Diabetic Ketoacidosis; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Infant, Newborn; | 2020 |
Permanent neonatal diabetes mellitus - a case report of a rare cause of diabetes mellitus in East Africa.
Topics: Administration, Oral; Child, Preschool; Diabetes Mellitus; Diabetic Ketoacidosis; Glyburide; Humans; | 2015 |
[Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].
Topics: Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Glyburide; Humans; Hypog | 2009 |
Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene.
Topics: Diabetic Ketoacidosis; DNA Mutational Analysis; Glyburide; Humans; Hypoglycemic Agents; Infant; Insu | 2011 |
Permanent neonatal diabetes due to KCNJ11 gene mutation.
Topics: Acute Kidney Injury; Amino Acid Substitution; Arginine; Blood Glucose; Cysteine; Diabetes Mellitus, | 2007 |
[Behavior of lactate and pyruvate in diabetics treated with a combination of fenformin and sulfonylurea in varying doses. I].
Topics: Adult; Aged; Chlorpropamide; Diabetes Mellitus; Diabetic Ketoacidosis; Drug Combinations; Female; Gl | 1980 |
Atypical ketoacidosis in type 2 diabetes.
Topics: Adult; Ambulatory Care; Clinical Protocols; Diabetes Complications; Diabetes Mellitus; Diabetes Mell | 1998 |
Lacticacidosis, ketoacidosis, and hyperalaninaemia in a phenformintreated diabetic patient.
Topics: Acetoacetates; Alanine; Amitriptyline; Bicarbonates; Blood Glucose; Chlorpropamide; Diabetes Mellitu | 1974 |
Insulin release in children with diet-treated diabetes.
Topics: Adolescent; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis | 1972 |